NUSIRT SCIENCES, INC.
Small-molecule therapeutic candidates for hypertension treatment targeting novel mechanisms of action
- Sector
- Biotech
- Headquarters
- NASHVILLE, TN
- Founded
- 2012
- Latest Form D
- $2M, Dec 2016
- Total capital
- $9.2M
- Federal grants
- $1.1M
- 1 award · 2025
- Rank in peer group#5 of 326
- Private capital raised
- $8.1M
- 3 Form D · last Dec 2016
- 119 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 22
- 18 pending · first 2015
- Rank in peer group#7 of 326
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Clinical validation of NS-0200, a fixed combination drug product for the treatment of hypertension$1.1M
- Private capital raisedForm D · SEC · 3rd filing$2M
- Private capital raisedForm D · SEC · 2nd filing$4M
- Private capital raisedForm D · SEC · 1st filing$2.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#5 · top 2%
- Granted patents#7 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Michael C. ZemelResearcherExecutive Officer, DirectorLinked by 10 patents · $1.1M in grants as PI
- Barbara CannonExecutive OfficerNamed in SEC Form D filings
- Brian C. LadenDirectorNamed in SEC Form D filings
- Eric C. SatzDirectorNamed in SEC Form D filings
- Joseph C. Cook, Jr.Executive Officer, DirectorNamed in SEC Form D filings
- Vaughn C. BrysonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 22 granted of 40- PendingCompositions, Methods And Kits For Altering AdipocytesUSPTOApplication 17740970
- PendingCompositions And Methods For Increasing Energy MetabolismUSPTOApplication 16843132
- GrantedCompositions And Methods For Increasing Energy MetabolismUSPTOUS 10,646,489
Show all 40 patent records
- Compositions, Methods And Kits For Altering AdipocytesDec 29, 2022 · Application 17740970Pending
- Compositions And Methods For Increasing Energy MetabolismOct 29, 2020 · Application 16843132Pending
- Compositions And Methods For Increasing Energy MetabolismMay 12, 2020 · US 10,646,489Granted
- Compositions And Methods For Modulating Metabolic PathwaysAug 20, 2019 · US 10,383,837Granted
- Compositions And Methods For Treating Metabolic DisordersJul 9, 2019 · US 10,344,002Granted
- Compositions And Methods For Modulating Metabolic PathwaysSep 18, 2018 · US 10,076,507Granted
- Compositions, Methods And Kits For Treatment Of Diabetes And/or HyperlipidemiaAug 23, 2018 · Application 15513115Pending
- Compositions, Method, And Kits For Treating Pulmonary ConditionsAug 7, 2018 · US 10,039,733Granted
- Compositions, Methods And Kits For Reducing Lipid LevelsAug 2, 2018 · Application 15851544Pending
- Compositions And Methods For The Reduction Or Prevention Of Hepatic SteatosisJun 21, 2018 · Application 15844101Pending
- Compositions And Methods For Increasing Energy MetabolismApr 17, 2018 · US 9,943,517Granted
- Compositions, Methods, And Kits For Regulating Energy MetabolismFeb 27, 2018 · US 9,901,573Granted
- Compositions, Methods And Kits For Reducing Lipid LevelsFeb 20, 2018 · US 9,895,357Granted
- Compositions And Methods For The Reduction Or Prevention Of Hepatic SteatosisJan 23, 2018 · US 9,872,844Granted
- Compositions And Methods For Modulating Metabolic PathwaysJan 2, 2018 · US 9,855,235Granted
- Compositions And Methods For The Reduction Or Prevention Of Non-alcoholic Steatohepatitis (nash)Aug 24, 2017 · Application 15447049Pending
- Compositions, Method, And Kits For Treating Pulmonary ConditionsAug 22, 2017 · US 9,737,501Granted
- Compositions And Methods For The Reduction Or Prevention Of Hepatic SteatosisAug 8, 2017 · US 9,724,319Granted
- Compositions, Methods, And Kits For Regulating Energy MetabolismJul 25, 2017 · US 9,713,609Granted
- Compositions, Methods And Kits For Reducing Lipid LevelsJul 18, 2017 · US 9,707,213Granted
- Compositions And Methods For Modulating Metabolic PathwaysJun 20, 2017 · US 9,682,053Granted
- Leucine And Nicotinic Acid Reduces Lipid LevelsMar 7, 2017 · US 9,585,876Granted
- Compositions, Methods And Kits For Reducing Lipid LevelsAug 9, 2016 · US 9,408,834Granted
- Compositions, Methods, And Kits For Regulating Energy MetabolismAug 9, 2016 · US 9,408,410Granted
- Compositions And Methods For Modulating Metabolic PathwaysMay 31, 2016 · US 9,351,967Granted
- Compositions, Methods, And Kits For Treatment Of PetsMar 17, 2016 · Application 14770148Pending
- Treatment Of Pets With Sirtuin ActivatorsJan 7, 2016 · Application 14770418Pending
- Treating Pulmonary ConditionsDec 17, 2015 · Application 14761283Pending
- Compositions, Methods, And Kits For Regulating Energy MetabolismDec 1, 2015 · US 9,198,454Granted
- Compositions And Methods For Modulating Metabolic PathwaysDec 1, 2015 · US 9,198,883Granted
- Compositions and Methods for Modulating Metabolic PathwaysJul 7, 2015 · US 9,072,692Granted
- Compositions, Methods, And Kits For Treatment Of PetsApplication PCTUS2014018418Pending
- Compositions, Methods And Kits For Altering AdipocytesApplication PCTUS2020059879Pending
- Compositions, Methods And Kits For Altering AdipocytesApplication 62933895Pending
- Compositions And Methods For The Reduction Or Prevention Of Hepatic Steatosis And NashApplication PCTUS2019018230Pending
- Compositions And Methods For The Reduction Or Prevention Of Hepatic Steatosis And NashApplication 62631164Pending
- Compositions And Methods For Treating Metabolic DisordersApplication PCTUS2017053448Pending
- Nitrogen Oxide Donors And Uses ThereofApplication PCTUS2017049946Pending
- Compositions And Methods For Treating Metabolic DisordersApplication 62399973Pending
- Nitrogen Oxide Donors And Uses ThereofApplication 62383254Pending
Related companies, and why
- ALIDA BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- RODIN THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- OSSIUM HEALTH INCSimilar federal contract value in Biotech · null in contracts
- CERSCI THERAPEUTICS INCORPORATEDSimilar federal contract value in Biotech · null in contracts
- ARMONICA TECHNOLOGIES, INC.Similar federal contract value in Biotech · null in contracts
- Oncoimmune IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .